TCL Archive NCI Grants: BSA Subcommittee Recommends Review Of SPORE Program In Year 2000 June 26, 1998
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005